Search Reports
Categories
Categories

Global Inactivated Polio Virus Vaccine Market

Global Inactivated Polio Virus Vaccine Market Research Report 2025(Status and Outlook)

Report Code : PHA1465
Published Date : 23 January, 2025 | No of Pages: 153

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Inactivated Polio Virus Vaccine (IPV) is a type of vaccine that provides immunity against poliovirus by using killed virus particles. IPV is administered through injection and is considered safe and effective in preventing polio. This vaccine is typically given in a series of doses to infants and young children as part of routine immunization programs. IPV is an essential tool in the global effort to eradicate polio and has played a significant role in reducing the incidence of the disease worldwide.

The market for Inactivated Polio Virus Vaccine is driven by several key factors. One of the primary market drivers is the continued commitment of governments and international organizations to eradicate polio globally. This has led to an increase in demand for IPV in both developed and developing countries. Additionally, advancements in vaccine technology and manufacturing processes have improved the efficacy and safety profile of IPV, further driving market growth. The growing awareness among healthcare professionals and the general public about the importance of vaccination in preventing infectious diseases like polio is also contributing to the expansion of the IPV market.

At the same time, market trends in the IPV segment include the introduction of combination vaccines that provide immunity against multiple diseases, including polio. This trend is driven by the need to simplify vaccination schedules and improve compliance rates among target populations. Furthermore, the increasing focus on immunization programs in emerging economies and the rise of public-private partnerships in vaccine distribution are shaping the market landscape for IPV. Overall, the market for Inactivated Polio Virus Vaccine is expected to witness steady growth in the coming years, driven by ongoing efforts to eradicate polio and improve access to vaccination services globally.
This report provides a deep insight into the global Inactivated Polio Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inactivated Polio Virus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inactivated Polio Virus Vaccine market in any manner.
Global Inactivated Polio Virus Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA

Market Segmentation (by Type)
Type I
Type II
Type III

Market Segmentation (by Application)
Hospital
Clinic

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Inactivated Polio Virus Vaccine Market
• Overview of the regional outlook of the Inactivated Polio Virus Vaccine Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Polio Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Inactivated Polio Virus Vaccine
      1.2 Key Market Segments
            1.2.1 Inactivated Polio Virus Vaccine Segment by Type
            1.2.2 Inactivated Polio Virus Vaccine Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Inactivated Polio Virus Vaccine Market Overview
      2.1 Global Market Overview
            2.1.1 Global Inactivated Polio Virus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Inactivated Polio Virus Vaccine Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Inactivated Polio Virus Vaccine Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Inactivated Polio Virus Vaccine Product Life Cycle
      3.3 Global Inactivated Polio Virus Vaccine Sales by Manufacturers (2020-2025)
      3.4 Global Inactivated Polio Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
      3.5 Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Inactivated Polio Virus Vaccine Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers Inactivated Polio Virus Vaccine Sales Sites, Area Served, Product Type
      3.8 Inactivated Polio Virus Vaccine Market Competitive Situation and Trends
            3.8.1 Inactivated Polio Virus Vaccine Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Inactivated Polio Virus Vaccine Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Inactivated Polio Virus Vaccine Industry Chain Analysis
      4.1 Inactivated Polio Virus Vaccine Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Inactivated Polio Virus Vaccine Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Market Restraints
      5.5 Industry News
            5.5.1 New Product Developments
            5.5.2 Mergers & Acquisitions
            5.5.3 Expansions
            5.5.4 Collaboration/Supply Contracts
      5.6 PEST Analysis
            5.6.1 Industry Policies Analysis
            5.6.2 Economic Environment Analysis
            5.6.3 Social Environment Analysis
            5.6.4 Technological Environment Analysis
      5.7 Global Inactivated Polio Virus Vaccine Market Porter's Five Forces Analysis
            5.7.1 Global Trade Frictions
            5.7.2 Global Trade Frictions and Their Impacts to Inactivated Polio Virus Vaccine Market
      5.8 ESG Ratings of Leading Companies
  6 Inactivated Polio Virus Vaccine Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Inactivated Polio Virus Vaccine Sales Market Share by Type (2020-2025)
      6.3 Global Inactivated Polio Virus Vaccine Market Size Market Share by Type (2020-2025)
      6.4 Global Inactivated Polio Virus Vaccine Price by Type (2020-2025)
  7 Inactivated Polio Virus Vaccine Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Inactivated Polio Virus Vaccine Market Sales by Application (2020-2025)
      7.3 Global Inactivated Polio Virus Vaccine Market Size (M USD) by Application (2020-2025)
      7.4 Global Inactivated Polio Virus Vaccine Sales Growth Rate by Application (2020-2025)
  8 Inactivated Polio Virus Vaccine Market Sales by Region
      8.1 Global Inactivated Polio Virus Vaccine Sales by Region
            8.1.1 Global Inactivated Polio Virus Vaccine Sales by Region
            8.1.2 Global Inactivated Polio Virus Vaccine Sales Market Share by Region
      8.2 Global Inactivated Polio Virus Vaccine Market Size by Region
            8.2.1 Global Inactivated Polio Virus Vaccine Market Size by Region
            8.2.2 Global Inactivated Polio Virus Vaccine Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Inactivated Polio Virus Vaccine Sales by Country
            8.3.2 North America Inactivated Polio Virus Vaccine Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Inactivated Polio Virus Vaccine Sales by Country
            8.4.2 Europe Inactivated Polio Virus Vaccine Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Inactivated Polio Virus Vaccine Sales by Region
            8.5.2 Asia Pacific Inactivated Polio Virus Vaccine Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Inactivated Polio Virus Vaccine Sales by Country
            8.6.2 South America Inactivated Polio Virus Vaccine Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Inactivated Polio Virus Vaccine Sales by Region
            8.7.2 Middle East and Africa Inactivated Polio Virus Vaccine Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Inactivated Polio Virus Vaccine Market Production by Region
      9.1 Global Production of Inactivated Polio Virus Vaccine by Region(2020-2025)
      9.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Region (2020-2025)
      9.3 Global Inactivated Polio Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Inactivated Polio Virus Vaccine Production
            9.4.1 North America Inactivated Polio Virus Vaccine Production Growth Rate (2020-2025)
            9.4.2 North America Inactivated Polio Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Inactivated Polio Virus Vaccine Production
            9.5.1 Europe Inactivated Polio Virus Vaccine Production Growth Rate (2020-2025)
            9.5.2 Europe Inactivated Polio Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Inactivated Polio Virus Vaccine Production (2020-2025)
            9.6.1 Japan Inactivated Polio Virus Vaccine Production Growth Rate (2020-2025)
            9.6.2 Japan Inactivated Polio Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Inactivated Polio Virus Vaccine Production (2020-2025)
            9.7.1 China Inactivated Polio Virus Vaccine Production Growth Rate (2020-2025)
            9.7.2 China Inactivated Polio Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Sanofi
            10.1.1 Sanofi Basic Information
            10.1.2 Sanofi Inactivated Polio Virus Vaccine Product Overview
            10.1.3 Sanofi Inactivated Polio Virus Vaccine Product Market Performance
            10.1.4 Sanofi Business Overview
            10.1.5 Sanofi SWOT Analysis
            10.1.6 Sanofi Recent Developments
      10.2 GSK
            10.2.1 GSK Basic Information
            10.2.2 GSK Inactivated Polio Virus Vaccine Product Overview
            10.2.3 GSK Inactivated Polio Virus Vaccine Product Market Performance
            10.2.4 GSK Business Overview
            10.2.5 GSK SWOT Analysis
            10.2.6 GSK Recent Developments
      10.3 Serum Institute (Bilthoven Biologicals)
            10.3.1 Serum Institute (Bilthoven Biologicals) Basic Information
            10.3.2 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Overview
            10.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Market Performance
            10.3.4 Serum Institute (Bilthoven Biologicals) Business Overview
            10.3.5 Serum Institute (Bilthoven Biologicals) SWOT Analysis
            10.3.6 Serum Institute (Bilthoven Biologicals) Recent Developments
      10.4 IMBCA
            10.4.1 IMBCA Basic Information
            10.4.2 IMBCA Inactivated Polio Virus Vaccine Product Overview
            10.4.3 IMBCA Inactivated Polio Virus Vaccine Product Market Performance
            10.4.4 IMBCA Business Overview
            10.4.5 IMBCA Recent Developments
  11 Inactivated Polio Virus Vaccine Market Forecast by Region
      11.1 Global Inactivated Polio Virus Vaccine Market Size Forecast
      11.2 Global Inactivated Polio Virus Vaccine Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Inactivated Polio Virus Vaccine Market Size Forecast by Country
            11.2.3 Asia Pacific Inactivated Polio Virus Vaccine Market Size Forecast by Region
            11.2.4 South America Inactivated Polio Virus Vaccine Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Inactivated Polio Virus Vaccine by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Inactivated Polio Virus Vaccine Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Inactivated Polio Virus Vaccine by Type (2026-2033)
            12.1.2 Global Inactivated Polio Virus Vaccine Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Inactivated Polio Virus Vaccine by Type (2026-2033)
      12.2 Global Inactivated Polio Virus Vaccine Market Forecast by Application (2026-2033)
            12.2.1 Global Inactivated Polio Virus Vaccine Sales (K MT) Forecast by Application
            12.2.2 Global Inactivated Polio Virus Vaccine Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Please select License
Single User Price:$ 2800
Site License Price:$ 3400
Enterprise Price:$ 3400